FSTX Insider Trading Activity and SEC Form 4 Filings
FSTX insider trading summary
No open-market insider purchases or sales of F-star Therapeutics, Inc. (FSTX) have been reported on SEC Form 4 in the past 12 months.
Latest FSTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2021 | Louis Kayitalire | Chief Medical Officer | Sell | $266 (39 @ $6.81) |
| Nov 2, 2021 | Louis Kayitalire | Chief Medical Officer | Sell | $171 (25 @ $6.85) |
| Oct 4, 2021 | Louis Kayitalire | Chief Medical Officer | Sell | $462 (64 @ $7.23) |
| Jul 2, 2021 | Louis Kayitalire | Chief Medical Officer | Sell | $9K (1,054 @ $8.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.